mon·o·nu·cle·ar

(mŏn′ō-no͞o′klē-ər, -nyo͞o′-)

adj.

1. Having only one nucleus: a mononuclear cell.

2. Chemistry Monocyclic.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

mononuclear

(ˌmɒnəʊˈnjuːklɪə)

adj

1. (Physiology) Also: mononucleate or mononucleated (of a cell) having only one nucleus

2. (Chemistry) another word for monocyclic¹

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

mon•o•nu•cle•ar

(ˌmɒn əˈnu kli ər, -ˈnyu- or, by metathesis, -kyə lər)

also mon•o•nu•cle•ate

(-kli ɪt, -ˌeɪt)

adj.

Biol. having only one nucleus.

[1885–90]

pronusg: See nuclear.

ThesaurusAntonymsRelated WordsSynonymsLegend:

Adj.

mononuclear - having only one nucleus

mononucleate

biological science, biology - the science that studies living organisms

binuclear, binucleate, binucleated - having two nuclei

trinuclear, trinucleate, trinucleated - having three nuclei

Translations

mon·o·nu·cle·ar

a. mononuclear, que tiene un solo núcleo;

___ cell → célula ___.

English-Spanish Medical Dictionary © Farlex 2012

Mentioned in

References in periodicals archive

RANCHO CORDOVA, Calif., February 25, 2019 -- ThermoGenesis Corp, a Cesca Therapeutics (NASDAQ: KOOL) company, has received Health Canada approval of its PXP System for point-of-care harvesting of purified mononuclear cells and platelets from blood or bone marrow.

Health Canada Okays ThermoGenesis' PXP System For Automated Processing Of Cells

ThermoGenesis Corp, a private corporation owned by Cesca Therapeutics, announced that it received Health Canada approval of its PXP System for point-of-care harvesting of purified mononuclear cells and platelets from blood or bone marrow.

ThermoGenesis granted Health Canada approval of PXP System

These products include the X-LAB System, for harvesting purified mononuclear cells from blood or bone marrow, the X-WASH System, for washing contaminants from cell suspensions and the PXP System, for 'Point of Care' harvesting of purified mononuclear cells and platelets from blood or bone marrow

ThermoGenesis completes construction and qualification of new Class 100,000, GMP compliant assembly facility

Stem cell company StemCyte revealed on Thursday the receipt of the US Food and Drug Administration's (FDA) approval for the start of its Phase II Investigational New Drug (IND) application for Allogeneic Human Leukocyte Antigen (HLA)-Matched Umbilical Cord Blood Mononuclear Stem Cells (UCBMNC) (MC001) for treating spinal cord injury.

StemCyte passes the US FDA's Phase II Investigational New Drug (IND) clearance for MC001 for spinal cord injury

2- Parenchymal inflammation was considered as mild (single inflammatory cells), moderate (inflammatory cells in groups of two-four) and severe (inflammatory cells in groups of five or more) and the type of inflammation was based on whether there were predominantly neutrophils, mixture of neutrophils and mononuclear cells and predominantly mononuclear cells (Figures 7 and 8).

The Effect of Ozone Treatment to the Inflammatory Response in Lung Contusion

A T-cell-mediated reaction is the important first step in the initiation of an immune response (12), also involving the secretion of the natural and adaptive immunity mediators and cytokines by peripheral blood mononuclear cells (PBMCs) (13, 14), and it is considered to play a major role in delayed gastrointestinal reactions to cow's milk proteins (15, 16).

Levels of inflammatory cytokines from peripheral blood mononuclear cells of children with cow's milk protein allergy

The trial would test whether transendocardial delivery of autologous bone marrow mononuclear cells to patients with high bone marrow potency markers will improve six minute walk distance and other clinically relevant endpoints.

Positive Safety Data From Phase 3 Trial Of Heart Failure Therapy

Recent findings showed increased mRNA expression for IL-22 in peripheral blood mononuclear cells (PBMC) from patients with asthma.

Expression of mRNA for IL-22 binding protein in the broncheoalveolar fluid after inhaled allergen challenge in subjects with asthma